4.8 Letter

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease Mendelian Randomization Investigation

Journal

CIRCULATION
Volume 141, Issue 22, Pages 1826-1828

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.120.045826

Keywords

Alzheimer disease; atherosclerosis; heart valve diseases; lipoprotein(a); Mendelian randomization analysis; stroke

Funding

  1. Swedish Heart-Lung Foundation (HjartLungfonden) [20190247]
  2. Swedish Research Council (Vetenskapsradet) [2019-00977]
  3. Swedish Research Council for Health, Working Life and Welfare (Forte) [2018-00123]
  4. Wellcome 4i Clinical PhD Program at Imperial College London
  5. Sir Henry Dale Fellowship - Wellcome Trust [204623/Z/16/Z]
  6. Royal Society [204623/Z/16/Z]
  7. Novartis
  8. UK Medical Research Council [MR/L003120/1]
  9. British Heart Foundation [RG/13/13/30194, RG/18/13/33946]
  10. National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust]
  11. Health Data Research UK - UK Medical Research Council
  12. Engineering and Physical Sciences Research Council
  13. Economic and Social Research Council
  14. Department of Health and Social Care (England)
  15. Chief Scientist Office of the Scottish Government Health and Social Care Directorates
  16. Health and Social Care Research and Development Division (Welsh Government)
  17. Public Health Agency (Northern Ireland)
  18. British Heart Foundation
  19. Wellcome
  20. British Heart Foundation [RG/13/13/30194, RG/18/13/33946] Funding Source: researchfish
  21. Medical Research Council [MR/L003120/1, HDR-9004] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available